SERA-SCANDIA A/S: Financial statements 2021
CVR: 14605185
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
SERA-SCANDIA A/S (CVR 14605185) has filed annual accounts for 2021. In 2021, the company reported revenue of DKK 242,301,000 and a net result of DKK 16,081,000 compared with DKK -16,558,000 the year before. That is an increase of 6,478.9% compared with the year before. The profit margin was 6.6%. Equity in the 2021 report amounted to DKK 62,020,000. The solvency ratio was 26.8%. The company had 176 employees in the financial year.
- Revenue
- DKK 242,301,000
- Gross Profit
- DKK 28,715,000
- Profit/Loss
- DKK 16,081,000
- Equity
- DKK 62,020,000
- Total Assets
- DKK 231,516,000
- Employees
- 176
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | 242.3M | 28.7M | 16.1M | 62M | 176 |
| 2020 | 3.7M | 433K | -16.6M | 50.3M | 186 |
| 2019 | 2.7M | 683K | -9.9M | 66.9M | 207 |
| 2018 | 2.7M | 345K | 23.4M | 63.2M | 220 |
| 2017 | 2.8M | 1.3M | 8M | 39.9M | 190 |
Official annual report
Find more companies like SERA-SCANDIA A/S
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
As of December 17, 2021, Jørn Martin Bank has joined the board of directors of SERA-SCANDIA A/S.
As of December 16, 2021, Jørn Martin Bank has left the board of directors of SERA-SCANDIA A/S.
SERA-SCANDIA A/S has published its annual report for 2020. Revenue came to DKK 3,683,000, and the net result was DKK -16,558,000.
About SERA-SCANDIA A/S
SERA-SCANDIA A/S is a Danish company of the type Aktieselskab based in Ballerup, founded in 1990. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named SERA-SCANDIA ApS and VICH 2604 ApS. The management consists of Troels Zakarias Glahn Kristiansen. The board consists of Ole Bødtker Nielsen (chair), Christian Lykkehus Sørensen and Nicolas Bødtker Nielsen. The company is owned by Danbiotech Inc.. The company has 16 employees (2026). In 2025, the company reported a gross profit of DKK 40,586,000 and a net result of DKK -7,801,000 compared with DKK 2,203,000 the year before. Equity in the 2025 report amounted to DKK 272,104,000.
